Eilers K - Search Results

1

Effect of calcitriol on prostate-specific antigen in vitro and in humans.

Beer TM, Garzotto M, Park B, Mori M, Myrthue A, Janeba N, Sauer D, Eilers K. Beer TM, et al. Among authors: eilers k. Clin Cancer Res. 2006 May 1;12(9):2812-6. doi: 10.1158/1078-0432.CCR-05-2310. Clin Cancer Res. 2006. PMID: 16675575

2

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer.

Beer TM, Eilers KM, Garzotto M, Egorin MJ, Lowe BA, Henner WD. Beer TM, et al. J Clin Oncol. 2003 Jan 1;21(1):123-8. doi: 10.1200/jco.2003.05.117. J Clin Oncol. 2003. PMID: 12506180 Clinical Trial.

3

Quality of life and pain relief during treatment with calcitriol and docetaxel in symptomatic metastatic androgen-independent prostate carcinoma.

Beer TM, Eilers KM, Garzotto M, Hsieh YC, Mori M. Beer TM, et al. Cancer. 2004 Feb 15;100(4):758-63. doi: 10.1002/cncr.20024. Cancer. 2004. PMID: 14770432 Free article. Clinical Trial.

4

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. Fromme EK, et al. Among authors: eilers km. J Clin Oncol. 2004 Sep 1;22(17):3485-90. doi: 10.1200/JCO.2004.03.025. J Clin Oncol. 2004. PMID: 15337796

5

Rationale for the development and current status of calcitriol in androgen-independent prostate cancer.

Beer TM, Myrthue A, Eilers KM. Beer TM, et al. World J Urol. 2005 Feb;23(1):28-32. doi: 10.1007/s00345-004-0476-y. Epub 2005 Jan 25. World J Urol. 2005. PMID: 15668801 Review.

6

Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancer.

Wagner M, Garzotto M, Lemmon D, Eilers KM, Beer TM. Wagner M, et al. Urology. 2005 Apr;65(4):799. doi: 10.1016/j.urology.2004.10.059. Urology. 2005. PMID: 15833548

7

C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial.

Beer TM, Lalani AS, Lee S, Mori M, Eilers KM, Curd JG, Henner WD, Ryan CW, Venner P, Ruether JD, Chi KN; ASCENT Investigators. Beer TM, et al. Cancer. 2008 Jun;112(11):2377-83. doi: 10.1002/cncr.23461. Cancer. 2008. PMID: 18428198 Free article. Clinical Trial.

8

Acupuncture for hot flashes in patients with prostate cancer.

Beer TM, Benavides M, Emmons SL, Hayes M, Liu G, Garzotto M, Donovan D, Katovic N, Reeder C, Eilers K. Beer TM, et al. Among authors: eilers k. Urology. 2010 Nov;76(5):1182-8. doi: 10.1016/j.urology.2010.03.033. Epub 2010 May 21. Urology. 2010. PMID: 20494414 Free PMC article. Clinical Trial.

9

Docetaxel (taxotere) in the treatment of prostate cancer.

Beer TM, El-Geneidi M, Eilers KM. Beer TM, et al. Expert Rev Anticancer Ther. 2003 Jun;3(3):261-8. doi: 10.1586/14737140.3.3.261. Expert Rev Anticancer Ther. 2003. PMID: 12820771 Review.

10

A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy.

Beer TM, Ryan C, Alumkal J, Ryan CW, Sun J, Eilers KM. Beer TM, et al. Anticancer Drugs. 2010 Apr;21(4):433-8. doi: 10.1097/CAD.0b013e3283355211. Anticancer Drugs. 2010. PMID: 20016365 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters